TERT promoter mutations were similarly associated with increased aggressiveness of human cancers, as exemplified by increased tumor recurrence and disease-specific mortality of PTC5 and aggressiveness of melanoma9,19, glioma, and bladder cancer20,21. Here, TERT is linked to neoplasm.